ABUS vs PYPL
Arbutus Biopharma Corp (ABUS) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the ABUS and PYPL stock pages for the full models.
Not investment advice.